Funding for this research was provided by:
Frederick National Laboratory for Cancer Research (HHSN261200800001E)
U.S. Department of Defense (HU00012120067)
Received: 17 February 2021
Accepted: 24 May 2021
First Online: 9 June 2021
: This study protocol was approved by the Uniformed Services University of the Health Sciences (USUHS) Institutional Review Board (FWA 00001628; DoD Assurance P60001) in compliance with all applicable Federal regulations governing the protection of human participants.All participants provided written informed consent for participation.
: All participants provided written informed consent for publication of study findings.
: The authors declare that they have no competing interests.